ArticleCPT: pharmacometrics & systems pharmacology2025

Model-Informed Precision Dosing of Infliximab in Korean Inflammatory Bowel Disease Patients: External Validation of Population Pharmacokinetic Models.

Yoonjin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.